Preferred Name |
vidarabine |
|
Synonyms |
9-Beta-D-arabinofuranosyladenine Monohydrate |
|
Definitions |
A nucleoside antibiotic isolated from the bacterium Streptomyces antibioticus with antineoplastic activity. Vidarabine inhibits DNA polymerase, resulting in the inhibition of DNA replication in tumor cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C929" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C929" NCI Thesaurus) |
|
ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000039150 |
|
altLabel |
9-Beta-D-arabinofuranosyladenine Monohydrate adenine arabinoside ARA-A araadenosine Vira-A 9-Beta-D-arabinofuranosyl-9H-purine-6-amine Monohydrate Beta Ara-A CI-673 Arabinosyladenine Spongoadenosine Arasena-A |
|
CAS Registry |
5536-17-4 |
|
cui |
C1519983 C0699565 C1527321 C0042646 |
|
Date last modified |
2006-12-12 |
|
definition |
A nucleoside antibiotic isolated from the bacterium Streptomyces antibioticus with antineoplastic activity. Vidarabine inhibits DNA polymerase, resulting in the inhibition of DNA replication in tumor cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C929" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C929" NCI Thesaurus) |
|
IND Code |
18288 8593 |
|
Legacy PDQ ID |
1770 |
|
LT |
TRD |
|
NCI ID |
C929 |
|
notation |
CDR0000039150 |
|
NSC Code |
404241 |
|
ORIG STY |
Drug/agent |
|
prefLabel |
vidarabine |
|
tui |
T114 T121 |